Alkermes (ALKS) 10-K2016 FY Annual report

Filed: 17 Feb 17, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: alleviate, ancillary, appellate, argument, ASU, ballot, billion, bore, Braeburn, California, circular, clarification, conversion, deconsolidation, derecognition, disulfiram, equitable, exert, exit, expend, frame, Gaffin, Germany, graphic, interlocutory, IPR, Italy, Kingdom, lipid, Luye, merged, Nanjing, nausea, opting, parallel, parent, permutation, PPACA, PROBUPHINE, Psychiatric, PTAB, reconsider, repeal, Reset, REXULTI, ROW, scenario, Shandong, shorter, simplification, simultaneously, slightly, sNDA, snyderman, Spain, standing, structure, subscale, suitable, Supreme, tapering, tendered, tool, transparency, TREVICTA, unchanged, USPTO, young

Removed: acquiree, advancing, Antler, balanced, banking, began, BYETTA, commenced, Commonwealth, defer, enroll, Forest, forming, history, left, Odyssey, participated, partnered, Peterson, preclinical, premium, Rebecca, referenced, secondary, TRICOR, unaudited, weekly

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ALKS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 21.1

SUBSIDIARIES


Name		Jurisdiction
Alkermes Ireland Holdings Limited		Ireland
Alkermes Pharma Ireland Limited		Ireland
Alkermes Finance Ireland Limited		Ireland
Daravita Pharma Ireland Limited		Ireland
Alkermes Finance Ireland (No. 3) Limited		Ireland
Alkermes Science Four Limited		Ireland
Alkermes Science Five Limited		Ireland
Alkermes Science Six Limited		Bermuda
Daravita Limited		Ireland
Alkermes Finance S.à r.l.		Luxembourg
Alkermes Finance Ireland (No. 2) Limited		Ireland
Alkermes U.S. Holdings, Inc.		Delaware
Alkermes, Inc.		Pennsylvania
Alkermes Controlled Therapeutics, Inc.		Pennsylvania
Alkermes Europe, Ltd.		United Kingdom

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.